Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
In Pinus spp, enhanced freezing tolerance during cold acclimation was characterized by elevated levels of APX, GR, MDHAR, and DHAR (Tao et al., 1998)
174 MoralesMMunn-BoschS
This carefully formulated blend delivers a quick and effective solution for replenishing your bodys nutrient levels
Factors That Deplete Levels Daily habits can easily drain your reserves: High stress and poor sleep Alcohol consumption or smoking Excessive exercise without recovery Environmental toxin exposure Why Supplementation Helps Fill the Gap Even with a balanced diet, maintaining optimal levels can be difficult
However, problems begin to occur when the number of free radicals exceeds what our bodies can process naturally, resulting in an increased presence of free radicals that can damage cells and compromise bodily functions
The trial did not resume enrollment Preclinical cardiac evidence: Animal models of myocardial infarction demonstrated RGN-352 reduced scar volume, improved cardiac function, and increased survival, forming the basis for the clinical program (PMID: 25015963) RGN-259 (Thymosin Beta-4 Ophthalmic Solution for Dry Eye): ARISE-1 and ARISE-2 Phase 3 trials: Evaluated Thymosin Beta-4 eye drops for dry eye disease with mixed results some endpoints showed improvement in signs of dry eye, but the pre-specified co-primary endpoints were not met, though some secondary endpoints showed statistically significant improvements in certain signs of dry eye (PMID: 23050815) These ophthalmic trials represent the most advanced clinical testing of any Thymosin Beta-4 formulation Independent Pilot Study (China, 2016): A small pilot study randomized 10 STEMI (heart attack) patients into two groups: 5 receiving Thymosin Beta-4-pretreated endothelial progenitor cells (EPCs) and 5 receiving untreated EPCs After 6 months, the Thymosin Beta-4-pretreated group showed trends toward improved cardiac function markers including ejection fraction and exercise capacity, though the very small sample size (n=5 per group) means these results should be considered hypothesis-generating only, not evidence of efficacy (PMID: 27288307) No severe complications were reported in either group during follow-up Important: This study used Thymosin Beta-4 as a cell pretreatment agent ex vivo (EPCs exposed to TB4 before transplantation), not as a directly administered drug
